Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kidron Capital Assets is a venture capital fund (founded 2021) focused on high-potential, underinvested "blue ocean" opportunities in women's health, spanning medical devices, therapeutics, diagnostics, and digital health. Kidron's inaugural portfolio includes companies with market-ready products (e.g., CE-approved device for acute kidney injury prevention), novel treatments for PCOS, menopause, and longevity applications, and new maternal health solutions[3][1][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kidron Capital Assets.